EGFR and lung adenocarcinoma: Surprisingly, as compared to the previous studies that showed that overexpression of CLDN-1 suppressed metastatic abilities of lung adenocarcinoma cells [50,57], this study showed that patients with positive expressions of both CLDN-1 and Ras/EGFR were found to have poor prognosis as compared to CLDN-1(+) Ras/EGFR(−), CLDN-1(−) Ras/EGFR(+), and CLDN-1(−) and Ras/EGFR(−) patients [119].